FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Micro Labs Limited)

View source ↗

Summary

FDA approved a supplemental application for Amoxicillin and Clavulanate Potassium from Micro Labs Limited under ANDA217805.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis
• Dental Abscess
• Intra-abdominal Infections
• Otitis Media
• Pneumonia Community-acquired
• Sinusitis
• Skin and Skin Structure Infections

Drugs mentioned

• AMOXICILLIN AND CLAVULANATE POTASSIUM (amoxicillin and clavulanate potassium)

Snippet

SUPPL AP for AMOXICILLIN AND CLAVULANATE POTASSIUM (AMOXICILLIN AND CLAVULANATE POTASSIUM)